You just read:

Oncolytics Biotech® Inc. Meets Primary Endpoint for First Part of U.S. Phase 2 Pancreatic Cancer Clinical Trial

News provided by

Oncolytics Biotech Inc.

Feb 14, 2011, 07:30 ET